HIV type 1 virological response and prevalence of HIV type 1 drug resistance among patients receiving antiretroviral therapy, Shandong, China

AIDS Research and Human Retroviruses
Jing ZhangChunfu Yang

Abstract

Shandong province has been providing antiretroviral therapy (ART) to eligible HIV/AIDS patients since 2003 using first-line regimens. We conducted a cross-sectional study to assess virological response and resistance development from ART patients. Between 2006 and 2008, blood was collected from 143 ART patients. Viral load (VL) was determined with a detection limit of 50 copies/ml; those with detectable VL were genotyped with dried plasma spots using a broadly sensitive genotyping assay. Resistance mutations were identified using the Stanford HIV drug resistance database. Of the 143 patients, 72% [95% confidence interval (CI): 65.9-78.2] suppressed their VL to <50 copies/ml. Genotyping analysis of the remaining 40 patients revealed that 21 (53%, CI: 37.0-68.0) harbored one or more mutations. The most common mutations were thymidine-analog mutations (22.5%) and M184V (10%) to nucleoside reverse transcriptase inhibitors (NRTIs), and V106I/A /M (17.5%), Y181C (15%), and H221Y (12.5%) to non-NRTIs (NNRTIs); 13 patients had mutations to both NRTIs and NNRTIs. Patients with VL >1000 copies/ml appear to harbor more mutations than those with VL between 50 and 1000 (62.1% vs. 27.3%, p>0.05). Resistance mutations were intensified among 1...Continue Reading

References

Dec 16, 2005·Cell Research·Jing Yun LiYi Ming Shao
May 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tommy F Liu, Robert W Shafer
Oct 5, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·David M MooreJulio S G Montaner
May 10, 2007·Molecular Biology and Evolution·Koichiro TamuraSudhir Kumar
Aug 19, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Moses R KamyaUNKNOWN Academic Alliance for AIDS Care and Prevention in Africa
Mar 5, 2008·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Somnuek SungkanuparphWasun Chantratita
Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vincent C MarconiUNKNOWN South Africa Resistance Cohort Study Team
Jul 17, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R E BarthH A Tempelman
Sep 16, 2008·AIDS Research and Human Retroviruses·Maria Mercedes SantoroCarlo Federico Perno
Sep 23, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·F MaldonadoR Zachariah
Jun 2, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Donato KoyaltaLaurent Bélec
Oct 6, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Carole L WallisWendy Stevens

❮ Previous
Next ❯

Citations

May 9, 2013·Future Virology·Naomi F WalkerRobert J Wilkinson

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
PCR

Software Mentioned

MEGA4
CLUSTAL W
HIVdb HIValg Program
REGA
HIValg
ChromasPro
BioEdit

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Nellie Wadonda-KabondoChunfu Yang
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Nellie Wadonda-KabondoDiane E Bennett
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Charlotte BoulléStratall ANRS 12110/ESTHER study group
© 2021 Meta ULC. All rights reserved